Publikationen, an denen er mitarbeitet Milagros Balbín Felechosa (20)

2023

  1. Fatal sclerosing mesenteritis: a 7-year-old male autopsy case report

    Autopsy and Case Reports, Vol. 13

2022

  1. Classification of follicular-patterned thyroid lesions using a minimal set of epigenetic biomarkers

    European journal of endocrinology, Vol. 187, Núm. 3, pp. 335-347

2019

  1. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas

    Head and Neck, Vol. 41, Núm. 1, pp. 79-91

2018

  1. TP53 p.R72P genotype is a marker of poor prognosis in lung cancer

    Cancer Biomarkers, Vol. 21, Núm. 4, pp. 747-754

2017

  1. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate

    Oncotarget, Vol. 8, Núm. 4, pp. 6700-6717

2016

  1. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

    Oncotarget, Vol. 7, Núm. 20, pp. 29780-29793

  2. Prognostic factors and survival study in high-grade glioma in the elderly

    British Journal of Neurosurgery, Vol. 30, Núm. 3, pp. 330-336

2013

  1. Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1αmiR-210 signaling pathway

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 10

  2. Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses

    Journal of Biological Chemistry, Vol. 288, Núm. 20, pp. 14647-14656

  3. Medullary thyroid carcinoma and 2q37 deletion in a patient with nevoid basal cell carcinoma syndrome: Clinical description and genetic analysis

    Head and Neck, Vol. 35, Núm. 5

2012

  1. EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas

    Cellular Oncology, Vol. 35, Núm. 6, pp. 443-450

  2. Identification of a signaling Axis HIF-1α/MicroRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 11

2011

  1. Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: A novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma

    BMC Cancer, Vol. 11

2010

  1. Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management

    Cellular Oncology, Vol. 32, Núm. 4, pp. 275-283

2009

  1. Chromosomal changes in sporadic and familial head and neck paragangliomas

    Otolaryngology - Head and Neck Surgery, Vol. 140, Núm. 5, pp. 724-729

2007

  1. A new type of NPM1 gene mutation in AML leading to a C-terminal truncated protein [4]

    Leukemia

  2. Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif [7]

    Leukemia

  3. Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8)

    FASEB Journal, Vol. 21, Núm. 10, pp. 2580-2591

2004

  1. Protein kinase C θ is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias

    Clinical Cancer Research, Vol. 10, Núm. 12 I, pp. 4089-4095

2003

  1. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice

    Nature Genetics, Vol. 35, Núm. 3, pp. 252-257